ARTICLE | Clinical News
Cesamet nabilone regulatory update
May 22, 2006 7:00 AM UTC
FDA approved a label change for Cesamet nabilone to treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional anti-emetic treatmen...